Prices of medicinal materials rise compressed by compressing profit. Chinese medicine companies overwhelm costs to expand their place of production
Release time: 2010-05-12 & nbsp & nbsp & nbsp Source:
When it comes to the price increase of Chinese medicine materials，Many Chinese medicine companies have begun to call bitter。Kangyuan Pharmaceutical (600557) Relevant persons said，Only the first quarter of this year，Three Seven、The price of honeysuckle rose greatly to the costs brought by Kangyuan Pharmaceutical, which was tens of millions of yuan a year -on -year，accounting for a quarter of the company's net profit in the first quarter。
As a domestic three -seven、The main origin of Chinese medicinal materials such as honeysuckle，Droughts in the Southwest region stake online sports bettingstake online sports bettinghave doubled the price of medicinal materials to double rises。But，Currently including Banlangen、Donkeys and other Chinese herbal medicinal materials have risen sharply，Chinese medicine companies are undergoing increasing cost pressure。
Stake Sports Betting
Relevant persons of Kangyuan Pharmaceutical introduced，Sanqi and honeysuckle are the main raw materials for the owner of Kangyuan Pharmaceutical Owner to Danjie Anti -Capsule and thermal poisoning injection，The purchase price of Sanqi rose from less than 100 yuan last year to more than 500 yuan，and honeysuckle from the level of 70-80 yuan/kg last year to the current 400 yuan，Company's main business cost rate in the fourth quarter of 2009, therefore increased by 2.22 percentage points compared to the first three quarters。
It is understood，The two major products of Kangyuan Pharmaceutical Sanjie Anti -Capsule Capsule and thermal Poison Ningju are included in the national medical insurance directory，Drugs are the highest price limit for the country。Therefore，From the above person,，Facing cost increases，Chinese medicine companies "short -term passive"。
Except Kangyuan Pharmaceutical，Task (600535)、Lizhu Group (000513) and other companies with Sanqi as the main raw materials are also undergoing cost pressure，while the price of Sanqi is soaring，The overall price of traditional Chinese medicine materials is also rising.。
Dong Ejiao (000423) The price of the main raw material stake sports betting appdonkey glue recently doubled Stake Sports Bettingto make Dong Ejiao eat，The rise in the price of white sugar and prince ginseng also allowed Jiangzhong Pharmaceutical (600750) to start the cost of shrinking food control。
The price of traditional Chinese medicinal materials rose，It seems except "natural disaster"，There are also "human disasters"。Some people in the industry said，It's not surprising that it is not surprising that it was not surprising that it was not surprising that it was a long time ago，Medical traders are waiting for the opportunity to stock up when medical prices fluctuate、The deviation of the supply and demand deviation is not uncommon，But the increase in the price of Sanqi this time is strange，The figure of the tour of the money has already appeared。
The government's regulation and control of real estate and the prosperity of the stock market have led to a number of money in the market that is eager to find new speculation bids，Chinese medicinal materials and even agricultural products are believed to be the next hotbed。
From the perspective of people in the medical industry，The possibility of traveling to the speculation of rare Chinese medicinal materials is not without，On the one hand, the price of Chinese medicinal materials in my country has risen in the past ten years.，with rigid color，On the other hand, meteorological disasters、Influenza epidemic and other unpredictable factors have also been given to the space of Youyou hype，But Chinese medicinal materials should not be stored for a long stake online sports bettingtime，stake sports betting appIts speculation has seasonal cycle，and the entire market is not large，The possibility of the community tour will not be too great。
Enterprise -saving costumes should be cost -high
or not compared to the tour of the capital，Chinese medicine companies are now paying more attention to how to solve the "urgent urgent" of high costs。
Facing high -cost "suspension sword"，Most traditional Chinese medicine companies have made two -handed preparation，One hand is compressed daily costs，If the management cost and energy consumption level is reduced、Increase technology and product output rate, etc.; One hand is to increase the amount of medicinal materials to increase the self -sufficiency rate，Rukangmei Pharmaceutical (600518) invested 1.5 billion yuan to build Huayu International Chinese Medicine City Project in Luzhou, Anhui;。
Although the impact of Sanqi price increases on Tasses is more obvious，Fortunately, Tasses have their own three -seven GAP planting bases in Wenshan Prefecture, Yunnan，Can relieve the company's cost pressure in a short time。
and Tongrentang (600085), the director Jia Zetao, the attitude of the increase in the cost of the medicinal materials, is even more calm。She said，The company’s Chinese medicine products are rich，The raw materials used in the used are not limited to several varieties，Relatively speaking，The risk of a substantial fluctuation of product costs has been dispersed and balanced; in addition，To avoid the risk of sudden increase in costs caused by emergencies。
And Kangyuan Pharmaceutical also continues to work hard in compression costs，Company relevant person said，The company also decided to launch a new product decentralized risk，At the same time, expand the market share with scale to change benefits，As he said，"Short -term very passive，Long -term practice internal skills "。
As a domestic three -seven、The main origin of Chinese medicinal materials such as honeysuckle，Droughts in the Southwest region stake online sports bettingstake online sports bettinghave doubled the price of medicinal materials to double rises。But，Currently including Banlangen、Donkeys and other Chinese herbal medicinal materials have risen sharply，Chinese medicine companies are undergoing increasing cost pressure。
Stake Sports Betting
Relevant persons of Kangyuan Pharmaceutical introduced，Sanqi and honeysuckle are the main raw materials for the owner of Kangyuan Pharmaceutical Owner to Danjie Anti -Capsule and thermal poisoning injection，The purchase price of Sanqi rose from less than 100 yuan last year to more than 500 yuan，and honeysuckle from the level of 70-80 yuan/kg last year to the current 400 yuan，Company's main business cost rate in the fourth quarter of 2009, therefore increased by 2.22 percentage points compared to the first three quarters。
It is understood，The two major products of Kangyuan Pharmaceutical Sanjie Anti -Capsule Capsule and thermal Poison Ningju are included in the national medical insurance directory，Drugs are the highest price limit for the country。Therefore，From the above person,，Facing cost increases，Chinese medicine companies "short -term passive"。
Except Kangyuan Pharmaceutical，Task (600535)、Lizhu Group (000513) and other companies with Sanqi as the main raw materials are also undergoing cost pressure，while the price of Sanqi is soaring，The overall price of traditional Chinese medicine materials is also rising.。
Dong Ejiao (000423) The price of the main raw material stake sports betting appdonkey glue recently doubled Stake Sports Bettingto make Dong Ejiao eat，The rise in the price of white sugar and prince ginseng also allowed Jiangzhong Pharmaceutical (600750) to start the cost of shrinking food control。
The price of traditional Chinese medicinal materials rose，It seems except "natural disaster"，There are also "human disasters"。Some people in the industry said，It's not surprising that it is not surprising that it was not surprising that it was not surprising that it was a long time ago，Medical traders are waiting for the opportunity to stock up when medical prices fluctuate、The deviation of the supply and demand deviation is not uncommon，But the increase in the price of Sanqi this time is strange，The figure of the tour of the money has already appeared。
The government's regulation and control of real estate and the prosperity of the stock market have led to a number of money in the market that is eager to find new speculation bids，Chinese medicinal materials and even agricultural products are believed to be the next hotbed。
From the perspective of people in the medical industry，The possibility of traveling to the speculation of rare Chinese medicinal materials is not without，On the one hand, the price of Chinese medicinal materials in my country has risen in the past ten years.，with rigid color，On the other hand, meteorological disasters、Influenza epidemic and other unpredictable factors have also been given to the space of Youyou hype，But Chinese medicinal materials should not be stored for a long stake online sports bettingtime，stake sports betting appIts speculation has seasonal cycle，and the entire market is not large，The possibility of the community tour will not be too great。
Enterprise -saving costumes should be cost -high
or not compared to the tour of the capital，Chinese medicine companies are now paying more attention to how to solve the "urgent urgent" of high costs。
Facing high -cost "suspension sword"，Most traditional Chinese medicine companies have made two -handed preparation，One hand is compressed daily costs，If the management cost and energy consumption level is reduced、Increase technology and product output rate, etc.; One hand is to increase the amount of medicinal materials to increase the self -sufficiency rate，Rukangmei Pharmaceutical (600518) invested 1.5 billion yuan to build Huayu International Chinese Medicine City Project in Luzhou, Anhui;。
Although the impact of Sanqi price increases on Tasses is more obvious，Fortunately, Tasses have their own three -seven GAP planting bases in Wenshan Prefecture, Yunnan，Can relieve the company's cost pressure in a short time。
and Tongrentang (600085), the director Jia Zetao, the attitude of the increase in the cost of the medicinal materials, is even more calm。She said，The company’s Chinese medicine products are rich，The raw materials used in the used are not limited to several varieties，Relatively speaking，The risk of a substantial fluctuation of product costs has been dispersed and balanced; in addition，To avoid the risk of sudden increase in costs caused by emergencies。
And Kangyuan Pharmaceutical also continues to work hard in compression costs，Company relevant person said，The company also decided to launch a new product decentralized risk，At the same time, expand the market share with scale to change benefits，As he said，"Short -term very passive，Long -term practice internal skills "。
